Everspin Technologies’ MRAM Stock Reaches 52-Week High Following U.S. Microchip Manufacturing Agreement

TLDR

• MRAM reached a new 52-week high of $23.10 on May 8, currently trading around $22.59 with a volume of approximately 437,000 shares.
• Everspin entered into a 10-year manufacturing agreement with Microchip Technology to expand U.S.-based MRAM production at an Oregon fabrication facility.
• The company reported Q1 earnings per share (EPS) of $0.11 and revenue of $14.87 million, surpassing the estimated $14.60 million.
• Q2 2026 EPS guidance is modest, ranging from $0.000 to $0.030; analyst consensus is Hold with an average target price of $18.50.
• CEO and CFO collectively sold about $796,000 worth of stock in early May.

---

(SeaPRwire) –   Everspin Technologies (MRAM) stock surged to a new 52-week peak of $23.10 on Friday, May 8, closing near $22.59. This marks a significant rise above its 50-day moving average of $11.18 and 200-day moving average of $10.63.

Everspin Technologies, Inc., MRAM

Trading volume for the day was approximately 437,000 shares, up from the previous close at $21.51.

The stock has appreciated roughly 25% recently, largely due to the announcement of a strategic partnership in April.

Details of the Microchip Agreement

On April 8, Everspin announced a 10-year collaboration with Microchip Technology to manufacture MRAM and Tunnel Magnetoresistive (TMR) sensor products at Microchip’s facility in Oregon.

The arrangement preserves Everspin’s ownership of intellectual property and process technology. It also introduces ITAR-compliant wafer processing capabilities, which are critical for defense and aerospace sector customers.

Everspin will continue operating its existing fabrication plant in Chandler, Arizona, alongside the new Oregon operations. Initial shipments from the Oregon line are anticipated in the second half of 2027.

The partnership can be extended by two-year terms beyond the initial decade-long contract.

Quarterly Results Met Expectations, but Outlook Remains Cautious

In Q1 2026, Everspin achieved EPS of $0.11 and generated revenue of $14.87 million, exceeding analyst forecasts of $14.60 million.

Net margin stood at 0.50%, while return on equity was recorded at 4.78%.

However, Q2 2026 guidance presents a more subdued outlook. The company expects EPS between $0.000 and $0.030—a broad and conservative range indicating near-term uncertainty.

With a market capitalization of $593 million and a price-to-earnings ratio of 2,532, the company remains in an early stage of profitability development.

Mixed Signals from Analysts and Insiders

Wall Street sentiment is divided. Needham increased its price target to $18.50 and maintained a Buy rating on April 30. Weiss Ratings retained a Sell rating as of March. Wall Street Zen downgraded the stock from Buy to Hold in February.

Overall, the consensus remains Hold, with an average target price of $18.50—significantly lower than the current trading level.

Insider activity has been notable: CEO Sanjeev Aggarwal sold 28,459 shares at $19.58 on May 4, realizing proceeds of about $557,000, which reduced his holdings by 3.36%.

CFO William Earl Cooper sold 11,000 shares at $21.75 on May 6, amounting to $239,250—a 6.39% reduction in his stake.

Together, insiders have offloaded approximately 60,448 shares valued at around $990,000 over the past three months.

Institutional investors hold a 44.68% ownership stake, with several hedge funds establishing new positions recently, including Raymond James Financial, Kestra Advisory Services, and Occudo Quantitative Strategies.

The stock carries a beta of 1.75, reflecting higher volatility relative to the broader market.